10.67 USD
-0.05 (-0.47%)
Taking everything into account, PSNL scores 3 out of 10 in our fundamental rating. PSNL was compared to 58 industry peers in the Life Sciences Tools & Services industry. While PSNL seems to be doing ok healthwise, there are quite some concerns on its profitability. PSNL is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
PSNL had negative earnings in the past year.
PSNL had a negative operating cash flow in the past year.
PSNL had negative earnings in each of the past 5 years.
PSNL had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -30.42%, PSNL is not doing good in the industry: 75.86% of the companies in the same industry are doing better.
PSNL's Return On Equity of -43.10% is on the low side compared to the rest of the industry. PSNL is outperformed by 68.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.42% | ||
| ROE | -43.1% | ||
| ROIC | N/A |
ROA(3y)-38.97%
ROA(5y)-30.04%
ROE(3y)-58.56%
ROE(5y)-43.57%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PSNL has a Gross Margin of 26.67%. This is in the lower half of the industry: PSNL underperforms 77.59% of its industry peers.
In the last couple of years the Gross Margin of PSNL has remained more or less at the same level.
PSNL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 26.67% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.05%
GM growth 5Y-1.31%
2. Health
2.1 Basic Checks
PSNL does not have a ROIC to compare to the WACC, probably because it is not profitable.
PSNL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for PSNL has been increased compared to 5 years ago.
The debt/assets ratio for PSNL has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.36 indicates that PSNL is not in any danger for bankruptcy at the moment.
PSNL has a better Altman-Z score (4.36) than 75.86% of its industry peers.
PSNL has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of PSNL (0.00) is better than 68.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.36 |
ROIC/WACCN/A
WACC10.06%
2.3 Liquidity
PSNL has a Current Ratio of 4.82. This indicates that PSNL is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 4.82, PSNL is doing good in the industry, outperforming 74.14% of the companies in the same industry.
A Quick Ratio of 4.69 indicates that PSNL has no problem at all paying its short term obligations.
PSNL has a Quick ratio of 4.69. This is amongst the best in the industry. PSNL outperforms 82.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.82 | ||
| Quick Ratio | 4.69 |
3. Growth
3.1 Past
PSNL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.62%, which is quite impressive.
Looking at the last year, PSNL shows a very negative growth in Revenue. The Revenue has decreased by -21.02% in the last year.
Measured over the past years, PSNL shows a small growth in Revenue. The Revenue has been growing by 5.35% on average per year.
EPS 1Y (TTM)47.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.5%
Revenue 1Y (TTM)-21.02%
Revenue growth 3Y-0.34%
Revenue growth 5Y5.35%
Sales Q2Q%-43.62%
3.2 Future
Based on estimates for the next years, PSNL will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.35% on average per year.
The Revenue is expected to grow by 14.60% on average over the next years. This is quite good.
EPS Next Y28.2%
EPS Next 2Y14.55%
EPS Next 3Y12.43%
EPS Next 5Y14.35%
Revenue Next Year-12.47%
Revenue Next 2Y6.6%
Revenue Next 3Y13.54%
Revenue Next 5Y14.6%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for PSNL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PSNL. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PSNL's earnings are expected to grow with 12.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.55%
EPS Next 3Y12.43%
5. Dividend
5.1 Amount
No dividends for PSNL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:PSNL (11/28/2025, 12:48:07 PM)
10.67
-0.05 (-0.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners49.09%
Inst Owner Change4.67%
Ins Owners1.17%
Ins Owner Change-0.22%
Market Cap947.50M
Revenue(TTM)69.10M
Net Income(TTM)-73.88M
Analysts82.86
Price Target10.84 (1.59%)
Short Float %12.08%
Short Ratio5.37
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.52%
Min EPS beat(2)7.49%
Max EPS beat(2)15.55%
EPS beat(4)4
Avg EPS beat(4)18.13%
Min EPS beat(4)7.49%
Max EPS beat(4)28.59%
EPS beat(8)6
Avg EPS beat(8)7.71%
EPS beat(12)8
Avg EPS beat(12)6.28%
EPS beat(16)11
Avg EPS beat(16)6.11%
Revenue beat(2)1
Avg Revenue beat(2)-4.68%
Min Revenue beat(2)-16.15%
Max Revenue beat(2)6.79%
Revenue beat(4)3
Avg Revenue beat(4)2.82%
Min Revenue beat(4)-16.15%
Max Revenue beat(4)15.99%
Revenue beat(8)6
Avg Revenue beat(8)5.8%
Revenue beat(12)9
Avg Revenue beat(12)5.37%
Revenue beat(16)12
Avg Revenue beat(16)5.55%
PT rev (1m)50.44%
PT rev (3m)44.07%
EPS NQ rev (1m)-5.05%
EPS NQ rev (3m)-7.44%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.92%
Revenue NQ rev (1m)-19.69%
Revenue NQ rev (3m)-19.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 13.71 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 5.53 | ||
| P/tB | 5.53 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.88
EYN/A
EPS(NY)-0.94
Fwd EYN/A
FCF(TTM)-0.75
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS0.78
BVpS1.93
TBVpS1.93
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.42% | ||
| ROE | -43.1% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 26.67% | ||
| FCFM | N/A |
ROA(3y)-38.97%
ROA(5y)-30.04%
ROE(3y)-58.56%
ROE(5y)-43.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.05%
GM growth 5Y-1.31%
F-Score3
Asset Turnover0.28
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 56.02% | ||
| Cap/Sales | 8.21% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.82 | ||
| Quick Ratio | 4.69 | ||
| Altman-Z | 4.36 |
F-Score3
WACC10.06%
ROIC/WACCN/A
Cap/Depr(3y)234.39%
Cap/Depr(5y)188.79%
Cap/Sales(3y)31.15%
Cap/Sales(5y)22.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.5%
EPS Next Y28.2%
EPS Next 2Y14.55%
EPS Next 3Y12.43%
EPS Next 5Y14.35%
Revenue 1Y (TTM)-21.02%
Revenue growth 3Y-0.34%
Revenue growth 5Y5.35%
Sales Q2Q%-43.62%
Revenue Next Year-12.47%
Revenue Next 2Y6.6%
Revenue Next 3Y13.54%
Revenue Next 5Y14.6%
EBIT growth 1Y-15.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-15.93%
EBIT Next 3Y-1.1%
EBIT Next 5Y15.71%
FCF growth 1Y13.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.5%
OCF growth 3YN/A
OCF growth 5YN/A
PERSONALIS INC / PSNL FAQ
Can you provide the ChartMill fundamental rating for PERSONALIS INC?
ChartMill assigns a fundamental rating of 3 / 10 to PSNL.
What is the valuation status for PSNL stock?
ChartMill assigns a valuation rating of 0 / 10 to PERSONALIS INC (PSNL). This can be considered as Overvalued.
What is the profitability of PSNL stock?
PERSONALIS INC (PSNL) has a profitability rating of 0 / 10.
What is the financial health of PERSONALIS INC (PSNL) stock?
The financial health rating of PERSONALIS INC (PSNL) is 6 / 10.